A court order allows a collection agency’s dispute over $500 medical debt reporting to enter the discovery phase.
12/16/2025 2:00 P.M.
2.5 minute read
A federal court recently issued an order in a case with significant implications for the accounts receivable management (ARM) industry, particularly concerning the credit reporting of medical debt.
In the case, Derrick Adams, et al. v. Experian Information Solutions, Inc., et al. (Case No. 2:23-cv-01773-DJC-JDP), the U.S. District Court for the Eastern District of California issued an order that allows an antitrust claim brought by a collection agency, AmeriFinancial Solutions, LLC, to move forward against Experian (and the other major credit reporting agencies, though only Experian is the named defendant in the order).
The core of the dispute challenges the agreement among the major consumer reporting agencies (CRAs) to no longer report certain types of medical debts, specifically those under $500.
Collection Agency Standing Upheld Under Sherman Act
The plaintiffs, which included a collection agency and medical practices, are challenging the CRAs’ policy under the federal Sherman Antitrust Act. The medical practices’ claims were dismissed in the court’s order, but the claim brought by the collection agency, AmeriFinancial Solutions, was allowed to continue.
The court found that it plausible that the collection agency had antitrust standing to sue Experian, meaning the CRAs’ policy directly injured the agency.
The court’s decision was based on two key plausible injuries for the collection agency:
- Direct Injury from the Agreement: The court found it plausible that the collection agency was directly harmed by the alleged agreement not to report certain medical debts.
- Decreased Value of Service: The court also found it plausible that the value of Experian’s credit reporting services, for which the collection agency is a furnisher, has decreased because of the agreement.
The alleged harm is premised on the argument that removing the credit reporting incentive for debts under $500 could plausibly encourage debtors not to pay those medical accounts, thereby injuring the collection agency’s ability to recover those debts.
Important Caveat: Only a Preliminary Ruling
ACA International members must understand the limited scope of this order.
- This court decision is not a final ruling on the merits of the case.
- The court has not definitively held that an antitrust violation occurred, nor has it ruled on the collection agency’s underlying claims.
- The court’s finding is only that the collection agency’s claims are plausible enough, particularly regarding standing, to overcome a motion to dismiss and allow the case to proceed to the discovery phase. The medical practices’ claims did not meet this threshold and were denied.
This case is a notable development given the current regulatory climate surrounding medical debt credit reporting, which has seen several major changes, including the CRAs’ voluntary removal of paid medical debts and collection accounts under $500.
ACA will continue to monitor this litigation closely, as the outcome may have broader implications.
Related:
- California District Court Partially Dismisses Class-Action Lawsuit Against CRAs
- Health Care Providers’ Class-Action Lawsuit Challenges CRAs’ Removal of Medical Bills Under $500
Remember, subscribe to ACA Daily and Member Alerts under your My ACA Assistant profile when logged in to acainternational.org.
A court order allows a collection agency’s dispute over $500 medical debt reporting to enter the discovery phase.





